Yan Palace(01497)
Search documents
燕之屋(01497) - 翌日披露报表
2025-10-21 09:44
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: 廈門燕之屋燕窩產業股份有限公司 (於中華人民共和國註冊成立的股份有限公司) 呈交日期: 2025年10月21日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01497 | 說明 | H股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | 庫存股份變動 | | | | | 事 ...
2023年燕窝行业词条报告
Tou Bao Yan Jiu Yuan· 2025-10-17 12:39
Investment Rating - The report indicates a positive investment outlook for the bird's nest industry, highlighting its growth potential and market expansion opportunities. Core Insights - The bird's nest industry is transitioning from a luxury product to a more accessible daily health supplement, driven by diverse consumer scenarios and innovative product forms. The market is expected to grow significantly due to structural expansion of consumer demographics and product innovation. Industry Overview - Bird's nest, made from the saliva of the swiftlet, is a high-end health supplement primarily produced in Indonesia and consumed in China, which accounts for over 80% of global consumption. The nutritional benefits include immune enhancement and metabolism promotion [4][5]. - The market size of China's bird's nest industry is projected to grow from 242.22 billion RMB in 2020 to 421.24 billion RMB by 2024, with a compound annual growth rate (CAGR) of 14.6% [36][37]. Industry Characteristics - **Diverse Consumption Scenarios and Product Innovation**: The consumption of bird's nest has expanded beyond traditional gifts and high-end supplements to include daily health, beauty, and maternal care. Product forms are evolving towards convenience, such as ready-to-eat and fresh-cooked options [15][16]. - **Standardized and Intelligent Production**: The industry is moving towards standardized production processes, with stricter regulations enhancing product quality control. Leading companies are adopting automated production lines to improve efficiency [17]. - **Integrated Industry Chain and Channel Fusion**: The industry is experiencing a shift from fragmented operations to integrated supply chains, with a focus on brand building and channel expansion. Online and offline sales channels are increasingly merging [18]. Market Development History - The bird's nest market in China began in the 1990s, facing challenges due to a lack of regulation and quality control. The "blood nest" incident in 2011 led to a comprehensive import ban, prompting the establishment of a traceability system and a new regulatory framework [19][22]. - From 2014 onwards, the market entered a rapid growth phase, with the introduction of ready-to-eat products and the rise of e-commerce platforms, significantly broadening the consumer base [20][23]. Industry Chain Analysis - **Upstream**: The supply of bird's nest is heavily reliant on imports from Malaysia and Indonesia, with a focus on standardization and quality control. As of 2024, 127 overseas bird's nest production enterprises are registered with China's customs [24][27]. - **Midstream**: Companies are shifting from traditional pure bird's nest products to high-value "bird's nest+" products, such as bird's nest porridge and beverages, to drive growth [25][31]. - **Downstream**: The consumer market is characterized by increased traceability awareness and diverse sales channels, with online sales accounting for approximately 45% and offline sales 55% [26][35]. Competitive Landscape - The bird's nest industry is marked by increasing brand concentration and intensified competition. Leading brands like Yan Zhi Wu and Xiao Xian Dun dominate the market, while smaller brands focus on e-commerce and niche marketing [44][45]. - The competitive dynamics are shaped by the scarcity of imported raw materials and the high stability requirements of the supply chain, creating significant barriers to entry for new players [45][46]. Future Outlook - The industry is expected to continue its trend towards high-end concentration and channel diversification, with leading brands enhancing their supply chain control and marketing strategies to maintain competitive advantages [46].
智通港股回购统计|10月17日





Zhi Tong Cai Jing· 2025-10-17 01:56
Summary of Key Points Core Viewpoint - A total of 30 companies conducted share buybacks on October 16, 2025, with Xiaomi Group-W leading in terms of buyback amount and quantity [1] Group 1: Buyback Details - Xiaomi Group-W (01810) repurchased 4 million shares for a total of 192 million [1] - Mengniu Dairy (02319) repurchased 1 million shares for 14.44 million [2] - Yun Gongchang (N23027) repurchased 2.01 million shares for 8.19 million [2] Group 2: Cumulative Buyback Data - Xiaomi Group-W has a cumulative buyback of 16.59 million shares, representing 0.060% of total share capital [2] - Mengniu Dairy has a cumulative buyback of 17.32 million shares, representing 0.443% of total share capital [2] - Yun Gongchang has a cumulative buyback of 20.62 million shares, representing 4.483% of total share capital [2] Group 3: Other Notable Buybacks - Lianyi Rong Technology-W (09959) repurchased 2.39 million shares for 7.48 million, with a cumulative total of 60.47 million shares, representing 2.830% of total share capital [2] - Kangning Jiere Pharmaceutical-B (09966) repurchased 400,000 shares for 5.48 million, with a cumulative total of 801,000 shares, representing 0.083% of total share capital [2] - Guisheng Tongqiao-B (02190) repurchased 50,000 shares for 1.24 million, with a cumulative total of 330,350 shares, representing 1.009% of total share capital [2]
燕之屋(01497.HK)10月16日耗资153万港元回购19万股
Ge Long Hui· 2025-10-16 09:56
格隆汇10月16日丨燕之屋(01497.HK)公告,10月16日耗资153万港元回购19万股,每股回购价8-8.08港 元。 ...
燕之屋(01497) - 翌日披露报表
2025-10-16 09:48
FF305 呈交日期: 2025年10月16日 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: 廈門燕之屋燕窩產業股份有限公司 (於中華人民共和國註冊成立的股份有限公司) 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01497 | H股 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份(不包括庫存股 ...
燕之屋(1497.HK)燕窝肽260万单场售罄,科技重塑传统
Ge Long Hui· 2025-10-16 05:03
Core Insights - YANPEP's first live-streaming event achieved a total GMV exceeding 2.6 million, with a star product selling out in one minute, indicating strong consumer interest and market potential [1][2] - The rapid market acceptance of YANPEP reflects a significant shift in consumer demand and a technological revolution in the health supplement sector [2] Group 1: Product Innovation - YANPEP addresses traditional pain points of bird's nest consumption, such as low absorption and inconvenience, by promoting "cellular energy nourishment" [3] - The brand has successfully extracted bird's nest peptides, which are seven times more absorbable than traditional bird's nest, enhancing its nutritional value [3] - YANPEP's product formats, including freeze-dried powders and portable bottled drinks, cater to modern consumer lifestyles [3] Group 2: Market Expansion - The initial success of YANPEP is just the beginning, with plans for further live-streaming and rapid product expansion [4] - YANPEP has launched bird's nest peptide milk, entering the liquid milk market valued at over 180 billion [4] - The brand is also expanding into probiotics targeting gut health, with a significant market opportunity as China is the second-largest probiotic consumer globally [4] - YANPEP is developing products specifically for pregnant women, tapping into a market projected to reach 230 billion by 2025 [4]
智通港股回购统计|10月15日





智通财经网· 2025-10-15 01:11
Summary of Key Points Core Viewpoint - A number of companies, including Xiaomi Group and Kuaishou, conducted share buybacks on October 14, 2025, with Xiaomi leading in terms of buyback amount and quantity [1]. Group 1: Buyback Details - Xiaomi Group-W (01810) repurchased 4 million shares for a total of 195 million, with a year-to-date total of 10.5954 million shares, representing 0.040% of its total share capital [2]. - Kuaishou-W (01024) repurchased 1.3146 million shares for 98.4067 million, with a year-to-date total of 3.4516 million shares, representing 0.081% of its total share capital [2]. - Shoucheng Holdings (00697) repurchased 16.05 million shares for 36.3578 million, with a year-to-date total of 90.146 million shares, representing 1.237% of its total share capital [2]. Group 2: Other Notable Buybacks - Vitasoy International (00345) repurchased 1.3980 million shares for 11.3964 million, with a year-to-date total of 4.25 million shares, representing 0.405% of its total share capital [2]. - IGG (00799) repurchased 150,000 shares for 6.145 million, with a year-to-date total of 17.809 million shares, representing 1.527% of its total share capital [3]. - China Hongqiao (01378) repurchased 300,000 shares for 7.594 million, with a year-to-date total of 154 million shares, representing 1.650% of its total share capital [2].
燕之屋10月14日斥资80.05万港元回购10万股
Zhi Tong Cai Jing· 2025-10-14 09:51
燕之屋(01497)发布公告,于2025年10月14日,该公司斥资80.05万港元回购10万股。 ...
燕之屋(01497.HK)10月14日耗资80.05万港元回购10万股
Ge Long Hui· 2025-10-14 09:49
格隆汇10月14日丨燕之屋(01497.HK)公告,10月14日耗资80.05万港元回购10万股,每股回购价8-8.01港 元。 ...
燕之屋(01497)10月14日斥资80.05万港元回购10万股
智通财经网· 2025-10-14 09:46
智通财经APP讯,燕之屋(01497)发布公告,于2025年10月14日,该公司斥资80.05万港元回购10万股。 ...